Lexeo Therapeutics, Inc.盘中异动早盘大幅拉升5.19%报2.84美元

市场透视2025-05-16

北京时间2025年05月16日21时30分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价大幅拉升5.19%。截至发稿，该股报2.84美元/股，成交量8520股，换手率0.03%，振幅1.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.66百万美元，每股收益-0.99美元，毛利-501000.00美元，市盈率-0.83倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535313173?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-16 21:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535313173","market":"us","top_or_hot":-1,"title":"Lexeo Therapeutics, Inc.盘中异动 早盘大幅拉升5.19%报2.84美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月16日21时30分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价大幅拉升5.19%。截至发稿，该股报2.84美元/股，成交量8520股，换手率0.03%，振幅1.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.66百万美元，每股收益-0.99美元，毛利-501000.00美元，市盈率-0.83倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621305394f90e78&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lexeo Therapeutics, Inc.盘中异动 早盘大幅拉升5.19%报2.84美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLexeo Therapeutics, Inc.盘中异动 早盘大幅拉升5.19%报2.84美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-16 21:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621305394f90e78&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月16日21时30分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价大幅拉升5.19%。截至发稿，该股报2.84美元/股，成交量8520股，换手率0.03%，振幅1.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.66百万美元，每股收益-0.99美元，毛利-501000.00美元，市盈率-0.83倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621305394f90e78&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621305394f90e78&s=b","article_id":"2535313173","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621305394f90e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535313173","pubTimestamp":1747402253,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月16日21时30分，Lexeo Therapeutics, Inc.股票出现异动，股价大幅拉升5.19%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用开创性科学从根本上改变疾病的治疗方式来改变医疗保健。该信息摘要如下：HC Wainwright & Co.：维持Lexeo Therapeutics评级，由买入调整至买入评级, 目标价由23.00美元调整至15.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BK4007":"制药","LXEO":"Lexeo Therapeutics","BK4539":"次新股","LENZ":"Therapeutics"},"translate_title":"Lexeo Therapeutics, Inc. surged 5.19% to $2.84 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"LXEO":1},"content_text":"北京时间2025年05月16日21时30分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价大幅拉升5.19%。截至发稿，该股报2.84美元/股，成交量8520股，换手率0.03%，振幅1.85%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.66百万美元，每股收益-0.99美元，毛利-501000.00美元，市盈率-0.83倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Inozyme Pharma, Inc.、Affimed N.V.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 (To Pur Com)涨幅较大，Polyrizon Ltd.、Affimed N.V.、Nucana Plc较为活跃，换手率分别为871.05%、609.34%、596.90%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 (To Pur Com)、Nucana Plc、Affimed N.V.，振幅分别为22.50%、9.36%、8.70%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用开创性科学从根本上改变疾病的治疗方式来改变医疗保健。该公司专注于临床前和临床阶段的基因治疗，特别是具有高度未满足需求的遗传和获得性疾病，这是其唯一的业务部门。消息层面，截至21时30分，《HC Wainwright & Co.：维持Lexeo Therapeutics评级，由买入调整至买入评级, 目标价由23.00美元调整至15.00美元。》资讯为影响Lexeo Therapeutics, Inc.的重要信息。该信息摘要如下：HC Wainwright & Co.：维持Lexeo Therapeutics(LXEO.US)评级，由买入调整至买入评级, 目标价由23.00美元调整至15.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535313173","isCrawlerRequest":true}

Lexeo Therapeutics, Inc.盘中异动 早盘大幅拉升5.19%报2.84美元

精彩评论

Lexeo Therapeutics, Inc.盘中异动早盘大幅拉升5.19%报2.84美元